Innovations in Cancer Care Q3 2024 | A promotional supplement distributed on behalf of Mediaplanet, which takes sole responsibility for its content
www.healthawareness.co.uk
The SACT Verification Passport could become a model for cancer pharmacy practice worldwide.
Digital innovation in cancer pharmacy professionals’ training The systemic anti-cancer therapies (SACT) Verification Passport is a digital solution allowing pharmacy staff to move between organisations and take a record of their training with them.
P
Netty Cracknell Lead Cancer Pharmacist, Member of the BOPA digital SACT Verification Passport project
@ Mediaplanet UK & IE
harmacy plays a crucial role in cancer treatment, particularly in managing chemotherapy and other SACT. These therapies — ranging from traditional chemotherapy to advanced immunotherapies and CAR-T cell treatments — are highly complex and carry significant risks, including severe side effects and death.
SACT Verification Passport solution The BOPA digital SACT Verification Passport is an innovative solution developed in partnership with the Compassly app. The passport delivers modules of training in the form of multiple choice questions, mock situations and tracks training as well as other features. It allows pharmacists to carry their certification between Specialist pharmacy training organisations, standardising the Not only does this Ensuring that each patient receives level of training across the UK. The boost efficiency, the right medicines, at the right passport saves time and resources but it also enhances by eliminating duplicate training doses and at the right time requires specialist pharmacists. These UK-wide while making it easier to the safety and professionals undergo extensive track and update qualifications quality of care for training beyond the five years of within organisations. cancer patients. university and foundation training, Not only does this boost which is required to legally qualify efficiency, but it also enhances the as a pharmacist within the UK. safety and quality of care for cancer patients. With global interest already growing, Training challenges the SACT Verification Passport could become a In 2022, the British Oncology Pharmacy model for cancer pharmacy practice worldwide. Association (BOPA) identified major inconsistencies in how this training is provided across the UK. Some organisations had overlapping training programmes, leading to inefficiencies when pharmacists moved between hospitals. @MediaplanetUK
Contact information: uk.info@mediaplanet.com or +44 (0) 203 642 0737
Jonathan Knight CEO and Co-Founder, Tefogo Member of the BOPA digital SACT Verification Passport project
Sarah Mitchell Cancer-Care Pharmacist, Member of the BOPA digital SACT Verification Passport project
Please recycle
Client Success Director UKIE: Ciara Barker ciara.barker@mediaplanet.com Managing Director UK: Ellie McGregor | Senior Designer: Aimee Rayment Junior Designer: Ellen Cahill Senior Content Manager: Angelica Hackett O’Toole | Head of Digital Operations: Harvey O’Donnell Paid Media Strategist: Jonni Asfaha Social & Web Editor: Henry Phillips | All images supplied by Getty Images, unless otherwise specified